Walgreens' Weak Market Trends a Woe, Strategic Deals to Aid

by Zacks Equity Research Published on April 10,2019

Walgreens Boots (WBA) currently endeavors to redress certain areas of operational weakness and reinforces its managerial competence to drive operating efficiency with a resolute focus.

• PEN Quick QuotePENNegative Net Change
• SYK Quick QuoteSYKPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change
• WBA Quick QuoteWBAPositive Net Change

• medical

Medtronic (MDT) Inks Value-Based Deal for Guardian Connect

by Zacks Equity Research Published on April 10,2019

Medtronic's (MDT) Guardian Connect system can now be accessed via a Blue Cross and Blue Shield of Minnesota member's pharmacy benefit.

• PEN Quick QuotePENNegative Net Change
• SYK Quick QuoteSYKPositive Net Change
• MDT Quick QuoteMDTNegative Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Bio-Rad's (BIO) IH-500 System Secures 510(K) From the FDA

by Zacks Equity Research Published on April 09,2019

The regulatory go-ahead is in line with Bio-Rad's (BIO) strategy of strengthening in the transfusion medicine market of the United States.

• PEN Quick QuotePENNegative Net Change
• BIO Quick QuoteBIONegative Net Change
• SYK Quick QuoteSYKPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Intersect ENT Grows on Product Launch Amid Pricing Pressure

by Zacks Equity Research Published on April 08,2019

Intersect ENT (XENT) recently finishes the ENCORE Study, which is a small 50-patient open label program, designed to evaluate the safety of the repeat use of SINUVA.

• XENT Quick QuoteXENTPositive Net Change
• PEN Quick QuotePENNegative Net Change
• SYK Quick QuoteSYKPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Natus Medical to Divest Medix for Focusing on Core Business

by Zacks Equity Research Published on April 08,2019

Per Natus Medical (BABY), this deal is strategically aligned with its business as besides concentrating on its core products, this sell-off will lead to planned investment in the high-growth markets.

• BABY Quick QuoteBABYPositive Net Change
• PEN Quick QuotePENNegative Net Change
• SYK Quick QuoteSYKPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Medtronic's New Data for HVAD System to Boost CRHF Segment

by Zacks Equity Research Published on April 08,2019

Medtronic's (MDT) latest data is expected to boost top-line contributions from the HeartWare HVAD System within the CRHF suite.

• PEN Quick QuotePENNegative Net Change
• MDT Quick QuoteMDTNegative Net Change
• ILMN Quick QuoteILMNPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Orthofix (OFIX) Reports Encouraging M6-C Disc Study Results

by Zacks Equity Research Published on April 08,2019

The primary goal of the study was to assess the safety and efficacy of Orthofix's (OFX) M6-C artificial cervical disc in comparison to ACDF treatment.

• PEN Quick QuotePENNegative Net Change
• SYK Quick QuoteSYKPositive Net Change
• OFIX Quick QuoteOFIXNegative Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

ResMed's (RMD) Brightree Unveils Analytics Platform for HME

by Zacks Equity Research Published on April 05,2019

The Analytics arm, launched by ResMed (RMD) unit Brightree, provides workflow insights and facilitates KPI tracking plus peer benchmarking without the users having to amass the data themselves.

• PEN Quick QuotePENNegative Net Change
• SYK Quick QuoteSYKPositive Net Change
• RMD Quick QuoteRMDPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

LabCorp (LH)-QIAGEN Form Alliance in In-Vitro Diagnostics

by Zacks Equity Research Published on April 04,2019

LabCorp's (LH) wide exposure in the companion diagnostics space further enhances QIAGEN's personalized health collaborations with the pharmaceutical bigwigs.

• SYK Quick QuoteSYKPositive Net Change
• QGEN Quick QuoteQGENPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change
• LH Quick QuoteLHPositive Net Change

• medical

ResMed (RMD) Rides on International Growth & Innovation

by Zacks Equity Research Published on April 04,2019

We expect ResMed's (RMD) new product menu and strategies to gain traction from the sleep-disordered breathing market and further drive its near-term performance.

• PEN Quick QuotePENNegative Net Change
• RMD Quick QuoteRMDPositive Net Change
• SYK Quick QuoteSYKPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Inogen (INGN) Launches One G5 Portable Oxygen Concentrator

by Zacks Equity Research Published on April 04,2019

Inogen's (INGN) product launch is in line with the company's strategy of providing innovative and long-term oxygen therapy to patients in need of respiratory aid.

• PEN Quick QuotePENNegative Net Change
• INGN Quick QuoteINGNNegative Net Change
• SYK Quick QuoteSYKPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Myriad Genetics New Study Data to Lift Prenatal Tests' Uptake

by Zacks Equity Research Published on April 04,2019

The recent development will help Myriad Genetics (MYGN) to boost top-line contributions from prenatal tests.

• PEN Quick QuotePENNegative Net Change
• MYGN Quick QuoteMYGNPositive Net Change
• ILMN Quick QuoteILMNPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Varian Announces Halcyon's First Successful Case in Malaysia

by Zacks Equity Research Published on April 03,2019

Varian's (VAR) Halcyon is much superior to traditional technologies, thanks to the speed of treatment and improved quality of patient care it offers.

• VAR Quick QuoteVARPositive Net Change
• PEN Quick QuotePENNegative Net Change
• SYK Quick QuoteSYKPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Bio-Rad's Latest FDA Nod to Boost Clinical Diagnostics Arm

by Zacks Equity Research Published on April 03,2019

The recent development will help Bio-Rad (BIO) rake in increased top-line contributions from the Clinical Diagnostics business.

• PEN Quick QuotePENNegative Net Change
• BIO Quick QuoteBIONegative Net Change
• ILMN Quick QuoteILMNPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Walgreens Boots (WBA) Q2 Earnings Lag Estimates, Margins Down

by Zacks Equity Research Published on April 02,2019

A difficult macroeconomic environment and market challenges made the fiscal second quarter the toughest since the formation of Walgreens Boots Alliance (WBA).

• PEN Quick QuotePENNegative Net Change
• RMD Quick QuoteRMDPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change
• WBA Quick QuoteWBAPositive Net Change

• earnings
• medical

Amedisys Closes Oklahoma-Based RoseRock Healthcare Buyout

by Sriparna Ghosal Published on April 02,2019

The acquisition of RoseRock Healthcare aligns with Amedisys' (AMED) strategy of foraying into the hospice care market of Oklahoma.

• VAR Quick QuoteVARPositive Net Change
• PEN Quick QuotePENNegative Net Change
• SYK Quick QuoteSYKPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Here's Why You Should Invest in Illumina (ILMN) Stock Now

by Zacks Equity Research Published on April 02,2019

Illumina (ILMN) is currently keeping well with its goals to strengthen foothold in the multi-billion gene sequencing market.

• PEN Quick QuotePENNegative Net Change
• RMD Quick QuoteRMDPositive Net Change
• ILMN Quick QuoteILMNPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Here's Why You Should Invest in ResMed (RMD) Stock Right Now

by Zacks Equity Research Published on April 01,2019

ResMed (RMD) continues to invest and expand presence in high-growth markets like China, South Korea, India, Brazil and many countries in Eastern Europe.

• HOLX Quick QuoteHOLXNegative Net Change
• PEN Quick QuotePENNegative Net Change
• RMD Quick QuoteRMDPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Genomic Health's New Positive Data to Boost Test Uptake

by Zacks Equity Research Published on April 01,2019

Genomic Health (GHDX) continues to see positive developments for Oncotype DX Breast Recurrence Score tests.

• PEN Quick QuotePENNegative Net Change
• HOLX Quick QuoteHOLXNegative Net Change
• GHDX Quick QuoteGHDXPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Amedisys (AMED) Down 3.5% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research Published on March 29,2019

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

• AMED Quick QuoteAMEDNegative Net Change

• earnings
• earnings-estimates
• earnings-performance
• earnings-report
• earnings-trend
• gold
• guidance
• margins
• revenue
• tech-stocks
• travel-leisure
• zacks-consensus-estimate

QIAGEN Unveils Liquid Biopsy Workflows & Panels, Widens Suite

by Zacks Equity Research Published on March 29,2019

QIAGEN (QGEN) is progressing well with its testing menu expansion strategy.

• PEN Quick QuotePENNegative Net Change
• HOLX Quick QuoteHOLXNegative Net Change
• QGEN Quick QuoteQGENPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

Here's Why You Should Buy IDEXX Laboratories (IDXX) Stock

by Zacks Equity Research Published on March 28,2019

The innovation-based, multi-modality global strategy, enabled by enhanced commercial capability, accelerates IDEXX's (IDXX) recurring CAG Diagnostics revenue growth.

• HOLX Quick QuoteHOLXNegative Net Change
• PEN Quick QuotePENNegative Net Change
• IDXX Quick QuoteIDXXPositive Net Change
• AMED Quick QuoteAMEDNegative Net Change

• medical

Buy These 5 Low Leverage Stocks for Safe Investing

by Zacks Equity Research Published on March 26,2019

Debt financing is preferred over equity financing owing to its cheap and easy availability. However, debt carries with it the burden of interest payment.

• WERN Quick QuoteWERNNegative Net Change
• FSS Quick QuoteFSSNegative Net Change
• AMED Quick QuoteAMEDNegative Net Change
• BOOM Quick QuoteBOOMNegative Net Change
• PCMI Quick QuotePCMIPositive Net Change

• consumer-discretionary
• industrial-products
• medical
• transportation

5 Stocks With Impressive Interest Coverage Ratio to Invest In

by Zacks Equity Research Published on March 25,2019

Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.

• FN Quick QuoteFNPositive Net Change
• SYY Quick QuoteSYYNegative Net Change
• AMED Quick QuoteAMEDNegative Net Change
• NSP Quick QuoteNSPNegative Net Change
• CBRE Quick QuoteCBREPositive Net Change

• business-services
• computers
• consumer-staples
• finance
• medical

Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

by Zacks Equity Research Published on March 25,2019

Sector ETF report for PTH

• PTH Quick QuotePTHPositive Net Change
• XLV Quick QuoteXLVPositive Net Change
• VHT Quick QuoteVHTPositive Net Change
• MASI Quick QuoteMASINegative Net Change
• EXAS Quick QuoteEXASNegative Net Change
• AMED Quick QuoteAMEDNegative Net Change

• dividend
• etf
• expenses
• holdings
• index
• tech-stocks
• us-equities